Type |
Details |
Score |
Publication |
First Author: |
Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas |
Year: |
2010 |
|
Title: |
Annotation inferences using phylogenetic trees |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Database and National Center for Biotechnology Information |
Year: |
2000 |
Journal: |
Database Release |
Title: |
Entrez Gene Load |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI) |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Consensus CDS project |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Group |
Year: |
2003 |
Journal: |
Database Procedure |
Title: |
Automatic Encodes (AutoE) Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bairoch A |
Year: |
1999 |
Journal: |
Database Release |
Title: |
SWISS-PROT Annotated protein sequence database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics |
Year: |
2010 |
Journal: |
Database Release |
Title: |
Protein Ontology Association Load. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and loading genome assembly coordinates from NCBI annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform |
|
|
|
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
231
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Allele |
Name: |
small nuclear ribonucleoprotein B; endonuclease-mediated mutation 1, Loydie Anne Jerome-Majewska |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Genotype |
Symbol: |
E2f1/E2f1<+> Snrpb/Snrpb<+> |
Background: |
involves: C3H * C57BL/6 * C57BL/6J * CD1 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 13, Marcus Bosenberg |
Allele Type: |
Transgenic |
Attribute String: |
Inducible, Recombinase |
|
•
•
•
•
•
|
Publication |
First Author: |
Thompson LW |
Year: |
2018 |
Journal: |
J Cell Sci |
Title: |
Neurochondrin interacts with the SMN protein suggesting a novel mechanism for spinal muscular atrophy pathology. |
Volume: |
131 |
Issue: |
8 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wan L |
Year: |
2017 |
Journal: |
Cancer Discov |
Title: |
The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function. |
Volume: |
7 |
Issue: |
4 |
Pages: |
424-441 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, endonuclease-mediated mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, endonuclease-mediated mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, endonuclease-mediated mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, endonuclease-mediated mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, endonuclease-mediated mutation, mutant strain, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, endonuclease-mediated mutation, mutant strain, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, endonuclease-mediated mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, endonuclease-mediated mutation, mutant strain, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2014 |
Journal: |
Pigment Cell Melanoma Res |
Title: |
Essential role of the molecular chaperone gp96 in regulating melanogenesis. |
Volume: |
27 |
Issue: |
1 |
Pages: |
82-9 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn2a/Cdkn2a Pten/Pten Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129/Sv * 129S1/Sv * C57BL/6J * FVB/N * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kras/Kras<+> Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129S4/SvJae * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129S1/Sv * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129S6/SvEvTac * C57BL/6 * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hsp90b1/Hsp90b1 Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
B6.Cg-Tg(Tyr-cre/ERT2)13Bos Hsp90b1 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Mc1r/Mc1r Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pikfyve/Pikfyve Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: C57BL/6 * C57BL/6J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: C57BL/6NCrlj * CBA/JNCrlj * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Liggins MC |
Year: |
2018 |
Journal: |
PLoS Genet |
Title: |
PIKfyve regulates melanosome biogenesis. |
Volume: |
14 |
Issue: |
3 |
Pages: |
e1007290 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shah M |
Year: |
2010 |
Journal: |
PLoS Genet |
Title: |
A role for ATF2 in regulating MITF and melanoma development. |
Volume: |
6 |
Issue: |
12 |
Pages: |
e1001258 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guendisch U |
Year: |
2022 |
Journal: |
Front Cell Dev Biol |
Title: |
Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation. |
Volume: |
10 |
|
Pages: |
916033 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shakhova O |
Year: |
2012 |
Journal: |
Nat Cell Biol |
Title: |
Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. |
Volume: |
14 |
Issue: |
8 |
Pages: |
882-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lissanu Deribe Y |
Year: |
2016 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma. |
Volume: |
113 |
Issue: |
9 |
Pages: |
E1296-305 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Bosenberg M |
Year: |
2006 |
Journal: |
Genesis |
Title: |
Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. |
Volume: |
44 |
Issue: |
5 |
Pages: |
262-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Harris ML |
Year: |
2013 |
Journal: |
Pigment Cell Melanoma Res |
Title: |
Postnatal lineage mapping of follicular melanocytes with the Tyr::CreER(T) (2) transgene. |
Volume: |
26 |
Issue: |
2 |
Pages: |
269-74 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Ferguson B |
Year: |
2010 |
Journal: |
Pigment Cell Melanoma Res |
Title: |
Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis. |
Volume: |
23 |
Issue: |
6 |
Pages: |
771-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang KJ |
Year: |
2017 |
Journal: |
Clin Cancer Res |
Title: |
A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon. |
Volume: |
23 |
Issue: |
8 |
Pages: |
2038-2049 |
|
•
•
•
•
•
|
Publication |
First Author: |
Young A |
Year: |
2017 |
Journal: |
Cancer Res |
Title: |
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis. |
Volume: |
77 |
Issue: |
17 |
Pages: |
4684-4696 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maertens O |
Year: |
2013 |
Journal: |
Cancer Discov |
Title: |
Elucidating distinct roles for NF1 in melanomagenesis. |
Volume: |
3 |
Issue: |
3 |
Pages: |
338-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Karreth FA |
Year: |
2011 |
Journal: |
Cell |
Title: |
In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. |
Volume: |
147 |
Issue: |
2 |
Pages: |
382-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shinzawa K |
Year: |
2023 |
Journal: |
Oncogene |
Title: |
GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation. |
Volume: |
42 |
Issue: |
42 |
Pages: |
3142-3156 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shakhova O |
Year: |
2015 |
Journal: |
PLoS Genet |
Title: |
Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. |
Volume: |
11 |
Issue: |
1 |
Pages: |
e1004877 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
González-Sánchez E |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas. |
Volume: |
8 |
Issue: |
6 |
Pages: |
e66933 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen CF |
Year: |
2017 |
Journal: |
Cell Rep |
Title: |
ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment. |
Volume: |
18 |
Issue: |
10 |
Pages: |
2331-2342 |
|
•
•
•
•
•
|
Publication |
First Author: |
Le Mercier I |
Year: |
2014 |
Journal: |
Cancer Res |
Title: |
VISTA Regulates the Development of Protective Antitumor Immunity. |
Volume: |
74 |
Issue: |
7 |
Pages: |
1933-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Crawford M |
Year: |
2020 |
Journal: |
J Invest Dermatol |
Title: |
Essential Role for Integrin-Linked Kinase in Melanoblast Colonization of the Skin. |
Volume: |
140 |
Issue: |
2 |
Pages: |
425-434.e10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yuan P |
Year: |
2013 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma. |
Volume: |
110 |
Issue: |
45 |
Pages: |
18226-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Katlinskaya YV |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression. |
Volume: |
15 |
Issue: |
1 |
Pages: |
171-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cesarini V |
Year: |
2017 |
Journal: |
Oncogene |
Title: |
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo. |
Volume: |
36 |
Issue: |
31 |
Pages: |
4508-4515 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shurin GV |
Year: |
2019 |
Journal: |
Cancer Res |
Title: |
Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth. |
Volume: |
79 |
Issue: |
10 |
Pages: |
2736-2747 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim SH |
Year: |
2017 |
Journal: |
J Invest Dermatol |
Title: |
Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma. |
Volume: |
137 |
Issue: |
8 |
Pages: |
1740-1748 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang F |
Year: |
2021 |
Journal: |
J Clin Invest |
Title: |
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses. |
Volume: |
131 |
Issue: |
8 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Lui JW |
Year: |
2019 |
Journal: |
J Cancer |
Title: |
The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma. |
Volume: |
10 |
Issue: |
1 |
Pages: |
1-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo X |
Year: |
2014 |
Journal: |
Cell Rep |
Title: |
Isolation and molecular characterization of circulating melanoma cells. |
Volume: |
7 |
Issue: |
3 |
Pages: |
645-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Di Leo L |
Year: |
2021 |
Journal: |
Nat Commun |
Title: |
Loss of Ambra1 promotes melanoma growth and invasion. |
Volume: |
12 |
Issue: |
1 |
Pages: |
2550 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brady DC |
Year: |
2017 |
Journal: |
Cancer Res |
Title: |
Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors. |
Volume: |
77 |
Issue: |
22 |
Pages: |
6240-6252 |
|
•
•
•
•
•
|
Publication |
First Author: |
Long JE |
Year: |
2019 |
Journal: |
Cell Death Differ |
Title: |
Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation. |
Volume: |
26 |
Issue: |
11 |
Pages: |
2416-2429 |
|
•
•
•
•
•
|
Publication |
First Author: |
Perna D |
Year: |
2015 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model. |
Volume: |
112 |
Issue: |
6 |
Pages: |
E536-45 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, congenic, transgenic, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Le Gal K |
Year: |
2015 |
Journal: |
Sci Transl Med |
Title: |
Antioxidants can increase melanoma metastasis in mice. |
Volume: |
7 |
Issue: |
308 |
Pages: |
308re8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Crawford M |
Year: |
2017 |
Journal: |
Biol Open |
Title: |
A reporter mouse model for in vivo tracing and in vitro molecular studies of melanocytic lineage cells and their diseases. |
Volume: |
6 |
Issue: |
8 |
Pages: |
1219-1228 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peng W |
Year: |
2016 |
Journal: |
Cancer Discov |
Title: |
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. |
Volume: |
6 |
Issue: |
2 |
Pages: |
202-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rahman H |
Year: |
2021 |
Journal: |
J Invest Dermatol |
Title: |
Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo. |
Volume: |
141 |
Issue: |
1 |
Pages: |
132-141.e3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pandita A |
Year: |
2021 |
Journal: |
Am J Pathol |
Title: |
Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma. |
Volume: |
191 |
Issue: |
11 |
Pages: |
2023-2038 |
|
•
•
•
•
•
|
Publication |
First Author: |
Muinonen-Martin AJ |
Year: |
2014 |
Journal: |
PLoS Biol |
Title: |
Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal. |
Volume: |
12 |
Issue: |
10 |
Pages: |
e1001966 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen HC |
Year: |
2018 |
Journal: |
Oncotarget |
Title: |
Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo. |
Volume: |
9 |
Issue: |
5 |
Pages: |
5861-5875 |
|
•
•
•
•
•
|
Publication |
First Author: |
Claps G |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis. |
Volume: |
15 |
Issue: |
9 |
Pages: |
1884-92 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pastura P |
Year: |
2024 |
Journal: |
Pediatr Blood Cancer |
Title: |
NRAS(Q61R) mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model. |
Volume: |
71 |
Issue: |
7 |
Pages: |
e31032 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu S |
Year: |
2018 |
Journal: |
Nat Commun |
Title: |
Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis. |
Volume: |
9 |
Issue: |
1 |
Pages: |
5426 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu B |
Year: |
2018 |
Journal: |
Nat Commun |
Title: |
The protective role of DOT1L in UV-induced melanomagenesis. |
Volume: |
9 |
Issue: |
1 |
Pages: |
259 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ruiz-Vega R |
Year: |
2020 |
Journal: |
Elife |
Title: |
Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes. |
Volume: |
9 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Chen S |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads. |
Volume: |
10 |
Issue: |
1 |
Pages: |
877 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn2a/Cdkn2a Ctnnb1/Ctnnb1 Pten/Pten Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129/Sv * C57BL/6J * FVB * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn2a/Cdkn2a<+> Kras/Kras<+> Trp53/Trp53<+> Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn2a/Cdkn2a Kras/Kras<+> Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn2a/Cdkn2a Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kras/Kras<+> Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
involves: 129S4/SvJae * C57BL/6 * FVB |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Braf/Braf Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/? TgTn(sb-T2/Onc)#Dla/? |
Background: |
involves: 129S6/SvEvTac * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Sox10/Sox10<+> Tg(Tyr-cre/ERT2)13Bos/? Tg(Tyr-NRAS*Q61K)1Bee/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6J * DBA/2 * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/? Tg(Tyr-NRAS*Q61K)1Bee/? |
Background: |
FVB.Cg-Tg(Tyr-cre/ERT2)13Bos Trp53 Tg(Tyr-NRAS*Q61K)1Bee |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
C3FeJ.Cg-Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor/Cvrk |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn2a/Cdkn2a Nras/Nras Tg(Tyr-cre/ERT2)13Bos/? |
Background: |
B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|